方案驱动方法缩短儿童钝性肝脾损伤患者住院时间
本回顾性研究对比2019年更新版美国小儿外科协会指南前后儿童钝性肝脾损伤(BLSI)患者的资源利用。旧方案组176例、新方案组170例,两组人口学、平均BLSI分级和校正ISS相似。多因素分析显示旧方案组ICU出院前天数显著更多(系数-0.3868,p<0.0009)、住院出院前天数显著更多(系数-0.5507,p<0.0001);新方案组费用有降低趋势(系数0.0921,p=0.1874),再入院率显著更高(系数-1.1731,p=0.0465),死亡率相当(系数0.0519,p=0.9710)。作者认为更新指南可缩短LOS,但需更大样本和详细费用分析探讨费用及再入院率升高的原因。
要点
- 更新版美国小儿外科协会指南管理下,ICU出院前天数显著少于旧方案组(系数-0.3868,p<0.0009)。
- 更新版指南管理下住院出院前天数显著少于旧方案组(系数-0.5507,p<0.0001)。
- 新方案组再入院率显著高于旧方案组(系数-1.1731,p=0.0465),死亡率两组相当(系数0.0519,p=0.9710)。
- 新方案组患者费用有降低趋势但未达统计学显著(系数0.0921,p=0.1874)。
适用人群与场景
- 年龄小于18岁、无严重非腹部损伤的钝性肝脾损伤患者,分别接受旧版(2015年4月至2019年6月)和更新版(2019年6月至2022年12月)指南管理。
研究设计与关键结果
- 回顾性研究,旧方案组176例、更新方案组170例,两组人口学、平均BLSI分级和校正ISS相似。
- 旧方案组ICU出院前天数显著更多(系数-0.3868,p<0.0009),住院出院前天数显著更多(系数-0.5507,p<0.0001)。
- 新方案组患者费用有降低趋势(系数0.0921,p=0.1874)。
- 新方案组再入院率显著更高(系数-1.1731,p=0.0465),死亡率两组相当(系数0.0519,p=0.9710)。
证据类型、等级与局限
- 证据类型:回顾性研究;证据等级:治疗/管理,Level III。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,按更新版美国小儿外科协会指南管理儿童钝性肝脾损伤可显著缩短ICU和住院时间,费用有降低趋势,死亡率相当,但再入院率更高;需更大样本和详细费用分析进一步探讨费用及再入院率升高的原因。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Our institution updated blunt liver and spleen injury (BLSI) protocols in 2019 in adherence to updated American Pediatric Surgery Association recommendations. This retrospective study compares resource utilization for pediatric BLSI patients treated under old and updated guidelines.
METHODS: Blunt liver and spleen injury patients without severe non-abdomen injuries younger than 18 years treated with prior (April 2015 to June 2019) and updated (June 2019 to December 2022) guidelines were retrospectively reviewed and compared. Each patient received an adjusted Injury Severity Score (ISS) to control for non-BLSI injuries. Multivariate analysis examined protocol group differences while controlling for adjusted ISS and BLSI grades. Primary outcomes were intensive care unit (ICU) length of stay (LOS), hospital LOS (analyzed using Cox regression), and patient costs (linear regression). Secondary outcomes include readmission in 2 weeks and death rates (logistic regression).
RESULTS: A total of 176 and 170 BLSI patients were treated with old and updated protocols, respectively. Patient demographics, average BLSI grade, and adjusted ISS were similar in both groups. Patients treated with old protocols indicate decreased hazard, showing significantly more days before ICU discharge (coefficient, -0.3868; p < 0.0009) and hospital discharge (coefficient, -0.5507; p < 0.0001). Patient costs (coefficient, 0.0921; p = 0.1874) trend toward being lower in the new protocol. Readmission rates were significantly higher in the new protocol (coefficient, -1.1731; p = 0.0465), and death rates (coefficient, 0.0519; p = 0.9710) were comparable.
CONCLUSIONS: Blunt liver and spleen injury patients treated under new American Pediatric Surgery Association guidelines compared with old guidelines had significant decreases in ICU and hospital LOS, a decreasing trend in costs, and comparable death rates but higher readmission rates. Future studies with larger sample sizes and detailed cost analysis would explore whether updated guidelines reduce patient costs and help elucidate the veracity or potential cause of the increased readmission rates.
LEVEL OF EVIDENCE: Therapeutic/Care Management; Level III.
参考来源
- Wang CC, Gupta A, Stone M, et al. A protocol-driven approach to reduce lengths of stay for pediatric blunt liver and spleen injury patients. J Trauma Acute Care Surg. 2024. PMID: 38277472. doi:10.1097/TA.0000000000004259
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。